Multisite Clinical Trials

Narrow List by Age:

(Refer to Clinical Summary for age requirements)

Multisite

Protocol URCC 18007
Cancer Type: Cancer-Related Fatigue
Fast Facts

Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue

Protocol URCC 19075
Cancer Type: multi-site
Fast Facts

URCC-19075 “Multi-Center Randomized Controlled Phase II Trial of Exercise to Treat Chemotherapy-Induced Peripheral Neuropathy (CIPN)”

Please check out the rare protocol list to locate other studies within this disease site.

Protocol TAPUR
Cancer Type: Multisite
Fast Facts

Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Protocol Alliance A071701
Cancer Type: Brain metastases
Fast Facts

Genomically-Guided Treatment Trial in Brain Metastases

Protocol EAY191 - A3
Cancer Type: Rare Cancer
Fast Facts

A COMBOMATCH TREATMENT TRIAL: PALBOCICLIB AND BINIMETINIB IN RAS-MUTANT CANCERS

Protocol EAY191 - S3
Cancer Type: Rare Cancer

Phase 2 Study of Paclitaxel + Ipatasertib in Taxane-Refractory
Participants with AKT-Altered Advanced Non-Breast Solid Tumors

Protocol Alliance EAY 191-A3
Cancer Type: Rare Cancer
Fast Facts

A ComboMATCH Treatment Trial: Palbociclib and Binimetinib in RAS-Mutant Cancers

Please check out the rare protocol list to locate other studies within this disease site.

Protocol 10323 Moonshot
Cancer Type: Biospecimen
Fast Facts

Cancer Moonshot Biobank Research Protocol

Please check out the rare protocol list to locate other studies within this disease site.

Protocol DCP-001
Cancer Type: Multisite - Screening

Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

Protocol EAY191
Cancer Type: Multisite
Fast Facts

Molecular Analysis for Combination Therapy Choice (ComboMATCH)

Please check out the rare protocol list to locate other studies within this disease site.

Cancer clinical trials are research studies for developing better ways of detecting, treating, and eventually preventing cancer. By taking part in a clinical trial, you are among the first to receive new research treatments before they are widely available. Your participation in a clinical trial will influence the future direction of cancer care.

If you are interested in participating in a clinical trial, consult with your physician. Please note: clinical trials are not risk free. Patients must explore the options that are best for their individuals needs with the help of their physician.